DE69201472D1 - Verhinderung der von Osteoklasten verursachten Knochenresorption durch Verwendung von substituierten Phenylderivaten. - Google Patents
Verhinderung der von Osteoklasten verursachten Knochenresorption durch Verwendung von substituierten Phenylderivaten.Info
- Publication number
- DE69201472D1 DE69201472D1 DE69201472T DE69201472T DE69201472D1 DE 69201472 D1 DE69201472 D1 DE 69201472D1 DE 69201472 T DE69201472 T DE 69201472T DE 69201472 T DE69201472 T DE 69201472T DE 69201472 D1 DE69201472 D1 DE 69201472D1
- Authority
- DE
- Germany
- Prior art keywords
- osteoclasts
- prevention
- substituted phenyl
- bone resorption
- phenyl derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/742,970 US5204350A (en) | 1991-08-09 | 1991-08-09 | Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69201472D1 true DE69201472D1 (de) | 1995-03-30 |
DE69201472T2 DE69201472T2 (de) | 1995-09-14 |
Family
ID=24986981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69201472T Expired - Fee Related DE69201472T2 (de) | 1991-08-09 | 1992-08-05 | Verhinderung der von Osteoklasten verursachten Knochenresorption durch Verwendung von substituierten Phenylderivaten. |
Country Status (5)
Country | Link |
---|---|
US (1) | US5204350A (de) |
EP (1) | EP0528587B1 (de) |
JP (1) | JPH0747537B2 (de) |
CA (1) | CA2075612A1 (de) |
DE (1) | DE69201472T2 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2186695A (en) * | 1994-03-18 | 1995-10-09 | Diatech, Inc. | Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis |
WO1995032710A1 (en) * | 1994-05-27 | 1995-12-07 | Merck & Co., Inc. | Compounds for inhibiting osteoclast-mediated bone resorption |
PT796855E (pt) | 1996-03-20 | 2002-07-31 | Hoechst Ag | Inibicao da reabsorcao nos ossos e antagonistas de vitronectina |
EP0925063A4 (de) | 1996-07-01 | 2000-12-27 | Lilly Co Eli | Blutzuckersenkende und lipidsenkende verbindungen |
DE19629816A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
DE19629817A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
WO1998015278A1 (en) * | 1996-10-07 | 1998-04-16 | Smithkline Beecham Corporation | Method for stimulating bone formation |
US6482821B2 (en) | 1996-12-20 | 2002-11-19 | Hoechst Aktiengellschaft | Vitronectin receptor antagonists, their preparation and their use |
US6218387B1 (en) | 1996-12-20 | 2001-04-17 | Hoechst Aktiengesellschaft | Vitronectin receptor anatagonists, their preparation and their use |
DE19653647A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung |
DE19653645A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung |
EP0933367A1 (de) * | 1997-12-19 | 1999-08-04 | Hoechst Marion Roussel Deutschland GmbH | Acylguanidin Derivate als Inhibitoren von Knochenaufsauge und als Vitronectin Rezeptor Antagonisten |
US6313119B1 (en) | 1998-01-23 | 2001-11-06 | Adventis Pharma Deutschland Gmbh | Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
EP0960882A1 (de) * | 1998-05-19 | 1999-12-01 | Hoechst Marion Roussel Deutschland GmbH | Thienyl substituiertre Acylguanidine und ihre Verwendung als Knochenresorptionhemmer und als Vitronectinrezeptor-Antagoniste |
CA2338275A1 (en) * | 1998-07-29 | 2000-02-10 | Merck & Co., Inc. | Integrin receptor antagonists |
US6204282B1 (en) | 1998-11-30 | 2001-03-20 | Schering Corporation | Benzimidazole compounds that are vitronectin receptor antagonists |
EP1028114A1 (de) | 1999-02-13 | 2000-08-16 | Aventis Pharma Deutschland GmbH | Neue Guanidin-Derivate als Inhibitoren der Zelladhäsion |
CN1374863A (zh) | 1999-07-21 | 2002-10-16 | 惠氏公司 | αvβ3整联蛋白的双环选择性拮抗剂 |
US6514964B1 (en) | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
EP1108721A1 (de) | 1999-12-15 | 2001-06-20 | Aventis Pharma Deutschland GmbH | Thienylalaninderivate als Inhibitoren der Zelladhäsion |
FR2847254B1 (fr) | 2002-11-19 | 2005-01-28 | Aventis Pharma Sa | Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant |
FR2870541B1 (fr) | 2004-05-18 | 2006-07-14 | Proskelia Sas | Derives de pyrimidines antigonistes du recepteur de la vitronectine |
DK2222636T3 (da) | 2007-12-21 | 2013-06-03 | Ligand Pharm Inc | Selektive androgenreceptormodulatorer (SARMS) og anvendelser deraf |
US10328082B2 (en) | 2014-05-30 | 2019-06-25 | Pfizer Inc. | Methods of use and combinations |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3365492D1 (en) * | 1982-01-27 | 1986-10-02 | Schering Ag | Diphosphonic acid derivatives and pharmaceutical preparations containing them |
US5055451A (en) * | 1986-12-22 | 1991-10-08 | Syntex Inc. | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
CA2033928A1 (en) * | 1990-01-11 | 1991-07-12 | Masahiko Sato | Compositions and methods for inhibiting osteoclast cellular adhesion to bone |
IL99537A (en) * | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
-
1991
- 1991-08-09 US US07/742,970 patent/US5204350A/en not_active Expired - Fee Related
-
1992
- 1992-08-05 EP EP92307157A patent/EP0528587B1/de not_active Expired - Lifetime
- 1992-08-05 DE DE69201472T patent/DE69201472T2/de not_active Expired - Fee Related
- 1992-08-07 CA CA002075612A patent/CA2075612A1/en not_active Abandoned
- 1992-08-10 JP JP4212980A patent/JPH0747537B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69201472T2 (de) | 1995-09-14 |
US5204350A (en) | 1993-04-20 |
EP0528587B1 (de) | 1995-02-22 |
CA2075612A1 (en) | 1993-02-10 |
JPH0747537B2 (ja) | 1995-05-24 |
JPH0656663A (ja) | 1994-03-01 |
EP0528587A1 (de) | 1993-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69201472D1 (de) | Verhinderung der von Osteoklasten verursachten Knochenresorption durch Verwendung von substituierten Phenylderivaten. | |
DE69201471D1 (de) | Verhinderung der durch Osteoklasten verursachten Knochenresorption durch aminoalkylsubstituierte Phenylderivate. | |
ATE227567T1 (de) | Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption | |
ATE269290T1 (de) | Benzoylderivate | |
DE59100762D1 (de) | Verwendung von Alkylcarbonsäure-dimethylamiden als Kristallisationsinhibitoren. | |
DE69200447D1 (de) | Erzeugung von russen. | |
MX9202727A (es) | Composiciones de lodo de perforacion. | |
DE69226763D1 (de) | Härten von fluoroelastomeren | |
DE69202164D1 (de) | Stabilisierung von Thiolenzusammensetzungen. | |
DE69204290D1 (de) | Verwendung von 1,2,2,3,3-pentafluorpropan. | |
DE69104947D1 (de) | Verhütung von Kesselstein. | |
DE59209936D1 (de) | Verwendung von Acetalen | |
DE59001751D1 (de) | Verwendung von di-styryl-phenyl-triglykolether als kristallisationsinhibitor. | |
ATE66675T1 (de) | Stickstoffhaltige heterozyklische verbindungen. | |
FI923163A0 (fi) | Foerfarande foer taetning av fogar i byggnader. | |
DK0642506T3 (da) | Heterocyclisk disubstituerede sulfonaminocarbonylforbindelser | |
FI925172A0 (fi) | Anordning foer reglering av luftstroemskraften i en vaermeanordning | |
DE69231883T2 (de) | 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten | |
DE3851386D1 (de) | Verwendung von Glycanen als antivirale Verbindungen. | |
FI943119A0 (fi) | Heterosyklisellä renkaalla substituoituja bentsyyliamiinijohdannaisia retrovirusvastaisina yhdisteinä | |
DE69205742D1 (de) | Keramisches Spielausgleichselement. | |
DE69205983D1 (de) | Beschichtung von substraten. | |
MX9202320A (es) | Composiciones cohesivas. | |
DE69221897T2 (de) | Herstellung von 2-(pyridyl)ethyl substituierte phosphor-verbindungen | |
DE69205986D1 (de) | Zusammensetzung von fluorwasserstoffsäure. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |